Global Neurology Clinical Trials Market Size & Outlook
Global neurology clinical trials market, 2018-2030 (US$M)
Related Markets
Global neurology clinical trials market highlights
- The global neurology clinical trials market generated a revenue of USD 5,838.8 million in 2024 and is expected to reach USD 8,424.8 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 6.4% by 2030.
- In terms of segment, phase iii accounted for a revenue of USD 2,608.8 million in 2024.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, South Korea is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 5,838.8 million |
| Market revenue in 2030 | USD 8,424.8 million |
| Growth rate | 6.4% (CAGR from 2025 to 2030) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III, Phase IV |
Other key industry trends
- In terms of revenue, the North America accounted for 47.0% of the global neurology clinical trials market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, South Korea is the fastest growing regional market and is projected to reach USD 174.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neurology Clinical Trials Market Scope
Neurology Clinical Trials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Cognition Health Partners | View profile | 11-50 | Panama City Beach, Florida, United States, North America | http://cognitionhealthpartners.com |
| BDD & Cie | View profile | 11-50 | Les Acacias, Geneve, Switzerland, Europe | https://www.bdd.ch |
| Alzheon | View profile | 11-50 | Framingham, Massachusetts, United States, North America | http://www.alzheon.com |
| Aurora Healthcare | View profile | 1001-5000 | Sydney, New South Wales, Australia, Oceania | https://aurorahealth.com.au |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| Labcorp Drug Development | View profile | 10001+ | Princeton, New Jersey, United States, North America | https://drugdevelopment.labcorp.com |
| Biogen Inc | View profile | 7570 | 225 Binney Street, Cambridge, MA, United States, 02142 | https://www.biogen.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
Global neurology clinical trials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neurology clinical trials market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 44.68% in 2024. Horizon Databook has segmented the Global neurology clinical trials market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Neurology Clinical Trials Phase Outlook (Revenue, USD Million, 2018-2030)
- Phase I
- Phase II
- Phase III
- Phase IV
- Global Neurology Clinical Trials Study Design Outlook (Revenue, USD Million, 2018-2030)
- Interventional
- Observational
- Expanded Access
- Global Neurology Clinical Trials Indication Outlook (Revenue, USD Million, 2018-2030)
- Alzheimer Disease
- Depression (MDD)
- Parkinson's Disease (PD)
- Epilepsy
- Stroke
- Traumatic Brain Injury (TBI)
- Amyotrophic Lateral Sclerosis (ALS)
- Huntington's Disease
- Muscle Regeneration
- Others
- Global Neurology Clinical Trials Value Chain Outlook (Revenue, USD Million, 2018-2030)
- In-house
- CROs
- Investigator Sites/Clinical Sites
Reasons to subscribe to Global neurology clinical trials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global neurology clinical trials market databook
-
Our clientele includes a mix of neurology clinical trials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global neurology clinical trials market , including forecasts for subscribers. This global databook contains high-level insights into Global neurology clinical trials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global neurology clinical trials market size, by regions, 2018-2030 (US$M)
Top 10 countries: Neurology clinical trials market size, 2024 (US$M)
Global neurology clinical trials market share, by phase, 2024 & 2030 (%, US$M)
Neurology clinical trials market: Opportunity assessment by country
Global neurology clinical trials market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
